Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2025-12-31 @ 8:44 PM
Study NCT ID:
NCT01419795
Status:
TERMINATED
Last Update Posted:
2017-07-27
First Post:
2011-08-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2467.00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |